Should governments rethink their coronavirus vaccine rollouts? | Inside Story

Your video will begin in 10
Skip ad (3)
China's top health official had admitted domestically produced jabs have low rates of protection.
Gao Fu said his country is considering options to boost the effectiveness of doses including mixing different brands.
That's as major side effects from other Covid-19 vaccines have slowed down vaccination drives elsewhere.
The U.S. has recommended 'pausing' the use of the Johnson & Johnson vaccine following reports of blood clots.
AstraZeneca's COVID-19 vaccine is being investigated by European regulators for similar cases..
And a new Israeli study has found the coronavirus variant discovered in South Africa can penetrate Pfizer-BioNTech’s COVID-19 vaccine to some extent.

So, do the coronavirus vaccines benefits still outweigh the risks?

Presenter: Dareen Abughaida


Patrick Tang, Division Chief of Microbiology at Sidra Medicine

Regina Osih, Medical Doctor and Infectious Diseases Specialist at The Aurum Institute

Jeffrey Lazarus, Head of Health Systems Research Group at Barcelona Institute for Global Health

- Subscribe to our channel:
- Follow us on Twitter:
- Find us on Facebook:
- Check our website:

#COVID-19 #Vaccine
News & Politics
Be the first to comment